XML 39 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Common Stock As of March 31, 2023, the par value of the Class A, Class B and Class C shares was $2,470, $275, and $56, respectively.

 

 

 

Shares
Authorized

 

 

Shares
Issued

 

 

Shares
Outstanding

 

Class A

 

 

1,000,000,000

 

 

 

247,762,793

 

 

 

247,762,793

 

Class B

 

 

100,000,000

 

 

 

27,390,397

 

 

 

27,390,397

 

Class C

 

 

200,000,000

 

 

 

5,555,555

 

 

 

5,555,555

 

 

 

 

1,300,000,000

 

 

 

280,708,745

 

 

 

280,708,745

 
Activity under Plans

Activity under the Plans is as follows:

 

 

Number of
Shares

 

 

Weighted
Average
Exercise Price

 

 

Weighted Average
Remaining
Contractual
Term (Years)

 

 

Aggregate
Intrinsic Value

 

Outstanding as of January 1, 2023

 

 

11,039,551

 

 

$

5.23

 

 

 

5.5

 

 

$

996

 

Granted

 

 

—

 

 

$

—

 

 

 

 

 

 

 

Forfeited

 

 

(173,320

)

 

$

5.80

 

 

 

 

 

 

 

Expired

 

 

—

 

 

$

—

 

 

 

 

 

 

 

Exercised

 

 

(128,572

)

 

$

2.25

 

 

 

 

 

 

 

Outstanding as of March 31, 2023

 

 

10,737,659

 

 

$

5.24

 

 

 

5.3

 

 

$

207

 

Vested and expected to vest as of December 31, 2022

 

 

10,951,967

 

 

$

5.02

 

 

 

5.5

 

 

$

996

 

Vested and expected to vest as of March 31, 2023

 

 

10,681,404

 

 

$

5.05

 

 

 

5.3

 

 

$

207

 

Options exercisable as of December 31, 2022

 

 

10,417,259

 

 

$

4.97

 

 

 

5.4

 

 

$

996

 

Options exercisable as of March 31, 2023

 

 

10,343,741

 

 

$

5.01

 

 

 

5.2

 

 

$

207

 
Summary of Unvested Restricted Stock Unit Activity

Activity for the restricted stock units is as follows:

 

 

 

Shares

 

 

Weighted Average
Grant Date
Fair Value

 

Unvested as of January 1, 2023

 

 

19,316,459

 

 

$

10.78

 

Granted

 

 

9,675,841

 

 

 

2.76

 

Vested

 

 

(2,781,161

)

 

 

7.17

 

Forfeited

 

 

(511,008

)

 

 

4.86

 

Unvested as of March 31, 2023

 

 

25,700,131

 

 

$

8.27

 
Summary of Performance-based Market Condition Share Awards

 

 

Shares

 

 

Weighted Average
Grant Date
Fair Value

 

Unvested as of January 1, 2023

 

 

25,602,405

 

 

$

2.30

 

Granted

 

 

2,654,598

 

 

 

2.19

 

Vested

 

 

(146,310

)

 

 

3.24

 

Cancelled/Forfeited

 

 

—

 

 

 

—

 

Unvested as of March 31, 2023

 

 

28,110,693

 

 

$

2.28

 
Schedule of Weighted Average Assumptions used to Determine Estimated Fair Value of Performance-based Market Condition Share Awards Granted

The weighted average estimated fair value of the performance-based market condition share awards granted during the three months ended March 31, 2023 was determined using a Monte-Carlo valuation simulation, with the following most significant weighted-average assumptions:

 

 

 

Three Months Ended March 31,

 

 

 

2023

 

Risk-free rate

 

 

4.61

%

Term to end of performance period (yrs)

 

3 years

 

Valuation date stock price

 

$

2.76

 

Expected volatility

 

 

70

%

Expected dividend yield

 

 

0

%
Stock-Based Compensation Expense

Stock-based compensation expense was classified in the condensed consolidated statements of operations and comprehensive loss as follows:

 

 

 

Three Months Ended March 31,

 

 

 

2023

 

 

2022

 

Cost of revenues

 

$

398

 

 

$

335

 

Research and development

 

 

2,801

 

 

 

2,182

 

Selling and marketing

 

 

1,986

 

 

 

1,795

 

General and administrative

 

 

15,812

 

 

 

7,773

 

Total

 

$

20,997

 

 

$

12,085